Schwarzenberger Paul

Radium-223 (Ra-223) Re-Treatment (Re-tx): First Experience From an International, Multicenter, Prospective Study in Patients (Pts) With Castration-Resistant Prostate Cancer and Bone Metastases (mCRPC).

S. Severi, O. Sartor, P. Schwarzenberger, 2016, Clinical advances in hematology & oncology : H&O.